| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/2001 | US6218115 Nucleotide sequence; recombinant production of cyclin protein; hybridization probes; diagnosis of or screening for cancer and immune disorders; anticarcinogenic agents |
| 04/17/2001 | US6218113 Human protein kinase C inhibitor |
| 04/17/2001 | US6218109 Mammalian checkpoint genes and proteins |
| 04/17/2001 | US6218103 Screening method by infecting cell having us3 gene under control of immediate early promoter with herpes virus lacking functional us3 gene, contacting with test compound, incubating for viral replication, comparing pathology with control |
| 04/17/2001 | US6218102 Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| 04/17/2001 | US6217893 Sustained-release compositions and method for preparing same |
| 04/17/2001 | US6217884 Isolated, purified polypeptide |
| 04/17/2001 | US6217883 Immunology response |
| 04/17/2001 | US6217881 Vaccine |
| 04/17/2001 | US6217879 Peptide mixture; hypotensive agents |
| 04/17/2001 | US6217872 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide |
| 04/17/2001 | US6217871 Generating an immune response to non-hodgkin lymphoma cell |
| 04/17/2001 | US6217870 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor |
| 04/17/2001 | US6217869 Administering antibody, antigen, ligand complex |
| 04/17/2001 | US6217864 Method for targeted degradation of intracellular proteins in vivo or ex vivo |
| 04/17/2001 | US6217862 Isolated polypeptide |
| 04/17/2001 | US6217861 pneumococcus; use as drug target for drug screening antibiotics |
| 04/17/2001 | US6217860 Supplying adenoviral vector into tumor |
| 04/17/2001 | US6217858 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 04/17/2001 | US6217857 Isolated polypeptide |
| 04/17/2001 | US6217847 Non-invasive localization of a light-emitting conjugate in a mammal |
| 04/17/2001 | US6217846 Synthetic peptides for use in thrombus detection |
| 04/17/2001 | CA2129747C Peptide for diagnosing and immunizing against t. cruzi infection |
| 04/17/2001 | CA2125985C Stem cell inhibiting proteins |
| 04/17/2001 | CA2110670C Spiro piperidines and homologs which promote release of growth hormone |
| 04/17/2001 | CA2087436C Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 04/17/2001 | CA2052323C Oligosaccharide conjugate vaccines |
| 04/13/2001 | CA2321260A1 Oral immunology using plant product containing hepatitis surface antigen |
| 04/13/2001 | CA2320741A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/13/2001 | CA2320518A1 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 04/12/2001 | WO2001025797A2 Methods of evaluating whether a test agent is an agent affecting a leptin receptor |
| 04/12/2001 | WO2001025793A2 Diagnosis of coeliac disease using a gliadin epitope |
| 04/12/2001 | WO2001025484A2 Methods to inhibit or enhance the binding of viral dna to genomic host dna |
| 04/12/2001 | WO2001025461A1 Utrophin gene promoter |
| 04/12/2001 | WO2001025456A2 Method for production of proteinaceous substances |
| 04/12/2001 | WO2001025455A2 Promoter for regulating expression of foreign genes |
| 04/12/2001 | WO2001025450A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | WO2001025447A1 Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 04/12/2001 | WO2001025440A1 C3 binding polypeptide of streptococcus agalactiae, group b streptococcus |
| 04/12/2001 | WO2001025439A1 Plant seed endosperm-specific promoter |
| 04/12/2001 | WO2001025438A2 Ifn-alpha homologues |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025434A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025432A2 Histamine receptor |
| 04/12/2001 | WO2001025431A1 Primate, particularly human, vomeronasal-like receptor |
| 04/12/2001 | WO2001025430A2 Novel human membrane proteins |
| 04/12/2001 | WO2001025429A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 04/12/2001 | WO2001025428A1 A novel human leptin homolog |
| 04/12/2001 | WO2001025427A1 Shear stress-response dna |
| 04/12/2001 | WO2001025426A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 04/12/2001 | WO2001025424A1 Recombinant antigen of taenia solium metacestodes |
| 04/12/2001 | WO2001025423A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 04/12/2001 | WO2001025421A2 Materials and method for detecting interaction of cftr polypeptides |
| 04/12/2001 | WO2001025416A1 Recombinant double hybrid filamentous bacteriophage |
| 04/12/2001 | WO2001025413A1 Use of a context-dependent functional entity to enhance the efficacy of an agent |
| 04/12/2001 | WO2001025410A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 04/12/2001 | WO2001025405A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | WO2001025401A2 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 04/12/2001 | WO2001025400A2 Compositions and methods for modulating atp-binding cassette transmembrane reporter protein expression |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025282A1 Il13 mutants |
| 04/12/2001 | WO2001025280A1 Paul, a g-protein coupled receptor |
| 04/12/2001 | WO2001025279A1 Cd29 pig protein, nucleic acid coding for said protein and the applications thereof |
| 04/12/2001 | WO2001025278A1 C-peptide for the improved production of insulin and insulin analogues |
| 04/12/2001 | WO2001025277A1 Single-chain antagonist polypeptides |
| 04/12/2001 | WO2001025276A1 Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination |
| 04/12/2001 | WO2001025275A1 Regulatory/unfolding peptides of ezrin |
| 04/12/2001 | WO2001025274A1 Mitofusins, fzo homologs and functional derivatives thereof |
| 04/12/2001 | WO2001025273A2 Compositions and methods for wt1 specific immunotherapy |
| 04/12/2001 | WO2001025272A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 04/12/2001 | WO2001025271A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | WO2001025270A2 PLANT APOPTOSIS INDUCING FACTORS (AIFs) |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025268A1 Human seizure related proteins |
| 04/12/2001 | WO2001025267A2 Improved ricin-like toxins for treatment of cancer |
| 04/12/2001 | WO2001025265A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | WO2001025258A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | WO2001025256A2 Trdl-1-gamma, a novel tumor necrosis-like ligand |
| 04/12/2001 | WO2001025255A2 Novel zinc finger protein |
| 04/12/2001 | WO2001025253A2 Temperature-sensitive regulation of viral vector production |
| 04/12/2001 | WO2001025250A1 Differentially expressed genes associated with her-2/neu overexpression |
| 04/12/2001 | WO2001024832A2 Pharmaceutical composition for treating and preventing human tumors, which express the tumor antigen mucin and/or the carcinoembryonic antigen (cea), and the use thereof |
| 04/12/2001 | WO2001024822A2 Pharmaceutical composition comprising an antigen |
| 04/12/2001 | WO2001024821A1 Nell-1 enhanced bone mineralization |
| 04/12/2001 | WO2001024820A1 Fusion proteins of mycobacterium tuberculosis |
| 04/12/2001 | WO2001024819A1 YsxC |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024811A1 April receptor (bcma) and uses thereof |
| 04/12/2001 | WO2001024810A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions |
| 04/12/2001 | WO2001024765A2 Antigenic modification of polypeptides |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO2001024681A2 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | WO2001024635A1 AsuE |
| 04/12/2001 | WO2001024628A1 Model animal of mesangial cell proliferative nephritis |
| 04/12/2001 | WO2001024625A1 Transgenic rodent comprising a polynucleotide emcoding a human ucp3 polynucleotide |
| 04/12/2001 | WO2000073328A3 Unc-5 constructs and screening methods |
| 04/12/2001 | WO2000068406A3 Disease resistance factors |
| 04/12/2001 | WO2000065063A3 Nucleic acid vaccines against rickettsial diseases and methods of use |